Abstract
To evaluate two methods for decreasing and/or diluting the FDG activity in the urinary system, five rats were intraperitoneally given 1,000 μg/g ofl-lysine 4 times, starting from 60 minutes before iv injection of FDG, and then at 30-minute intervals for 90 minutes. Five rats were used as controls. In a furosemide study, 12 rats were allocated to three groups. Group 1 received iv injection of FDG alone. Group 2 received saline before iv injection of FDG. Group 3 received furosemide (7 mg/kg) and saline (1/30 of body weight). Neither renal uptake nor urinary excretion of FDG had a statistically significant difference: renal uptake; 0.179 ± 0.011 (l-lysine) vs. 0.119 ± 0.003 (control) % kg injected dose/g. The % dose excreted and total urine volume were: 15.0 ± 2.5 to 15.5 ± 2.5 with 2.98 ml (l-lysine), 22.9 ± 1.8 to 24.2 ± 1.5 with 1.41ml (control). The furosemide study revealed a statistically significant difference: Group 1; 7.57 ± 4.73, Group 2; 0.686 ± 0.638, Group 3; 2.37 ± 2.33% kg injected dose/g (p < 0.01 for Group 1 vs. Group 2, p < 0.05 for Group 1 vs. Group 3). While pretreatment withl-lysine or furosemide failed to decrease renal activity of FDG, saline injection without furosemide markedly decreased urinary activity.
Similar content being viewed by others
References
Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-d-glucose (F-18): nontoxic tracer for rapid tumor detection.J Nucl Med 21: 670–675, 1980.
Larson SM, Weiden PL, Grunbaum Z, et al: Positron imaging feasibility studies. II. Characteristic of deoxyglucose uptake in rodent and canine neoplasms: concise communication.J Nucl Med 22: 875–879, 1981.
Wahl RL, Hutchins G, Liebert M, Grossman HB, Buchsbaum D, Fisher S.18FDG uptake in human tumor xenografts: feasibility studies for cancer imaging.J Nucl Med 31: 912, 1989.
Wahl RL, Kaminski MS, Ethier SP, Hutchins GD. The potential of 2-deoxy-2[18F]fluoro-d-glucose for the detection of tumor involvement in lymph nodes.J Nucl Med 31: 1831–1835, 1990.
Higashi K, Clavo AC, Wahl RL.In vitro assessment of 2-fluoro-2-deoxy-d-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.J Nucl Med 34: 773–779, 1993.
Whal RL. Positron emission tomography: application in oncology.In: Murray PC, Ell PJ, eds. Nuclear Medicine in Clinical and Treatment. Edinburgh: Churchill Livingstone, pp. 801–820, 1994.
Hamey JV, Wahl RL, Liebert M, Huhl DE, Hutchins GD, Wedemeyer G, et al. Uptake of 2-deoxy,2-(18F)fluoro-d-glucose in bladder cancer: animal localization and initial patient positron emission tomography.J Urol 145: 279–283, 1991.
Kawamura J, Hida S, Yoshida O, Yonekura Y, Senda M, Yamamoto K, et al. Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-d-glucose (FDG) in patients with renal cell carcinoma (preliminary report).KAKU IGAKU (Jpn J Nucl Med) 25: 1143–1148, 1988.
Wahl RL, Hamey J, Hutchins G, Grossman HB. Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-d-glucose: pilot animal and human studies.J Urol 146: 1470–1474, 1991.
Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-d-glucose.J Compt Assist Tomogr 17: 582–589, 1993.
Brown RS, Fisher SJ, Wahl RL. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-d-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma.J Nucl Med 34: 75–82, 1993.
Wahl RL, Greenough R, Clark MF, Grossman HB. Initial evaluation of FDG/PET imaging of metastatic testicular neoplasms.J Nucl Med 34: 6p, 1993. (abstract)
Wahl RL, Hutchins GD, Roberts J. FDG PET imaging of ovarian cancer: Initial evaluation in patients.J Nucl Med 32: 982, 1991.
Hammond PJ, Wade AF, Gwilliam ME, Peters AM, Myers MJ, Gilbey SG, et al. Amino acid infusion blocks renal tubular uptake of indium-labelled somatostatin analogue.Br J Cancer 67: 1437–1439, 1993.
Pimm MV, Gribben SJ. Prevention of renal tubule reabsorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine.Eur J Nucl Med 21: 663–665, 1994.
Behr TM, Sharkey RM, Juweid ME, Blumenthal RD, Dunn RM, Griffiths GL, et al. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.Cancer Res 55: 3825–3834, 1995.
Toorongian SA, Mulholland GK, Jewett DM, Bachelor MA, Kilbourn MR. Routine production of 2-deoxy-2-[18F]fluoro-d-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridium resin.Int J Radiat Appl Instrum 17: 273–279, 1990.
Wahl RL, Hawkins RA, Larson SM, Hendee WR, Coleman RE, Holden RW, et al. Proceedings of a National Cancer Institute workshops: PET in oncology—a clinical research agenda.Radiology 193: 604–606, 1994.
Gallagher BM, Ansari A, Atkins H, Casella V, Christman DR, Fowler JS, et al. Radiopharmaceuticals XXVII.18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharma-ceutical for measuring regional myocardial glucose metabolismin vivo: tissue distribution and imaging studies in animals.J Nucl Med 18: 990–996, 1977.
Wahl RL, Kaminski MS, Ethier SP, Hutchins GD. The potential of 2-deoxy-2[18F]fluoro-d-glucose (FDG) for the detection of tumor involvement in lymph nodes.J Nucl Med 31: 1831–1835, 1990.
Morgenson CE, Sølling K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids.Scand J Clin Lab Invest 37: 477–486, 1977.
Schwegler JS, Silbernagl S, Tamarappoo BK, Welbourne TC. Amino acid transport in the kidney.In: Kiberg MS, Haussinger D, eds. Mammalian Amino Acid Transport. New York: Plenum Press, pp. 233–260, 1992.
Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, et al. Molecular biology mammalian glucose transporters.Diabetes Care 13: 198–208, 1990.
Hediger MA, Rhoads DB. Molecular physiology of sodium-glucose cotransporters.Physiol Rev 74: 993–1026, 1994.
Hediger MA, Turk E, Wright EM. Homology of the human intestinal NaVglucose and Escherichia coli Na+/proline cotransporters.Proc Natl Acad Sci USA 86: 5748–5752, 1989.
Ikeda TS, Hwang E-S, Coady MJ, Hirayama BA, Hediger MA, Wright EM. Characterization of a Na+/glucose cotransporter clined from rabbit small intestine.J Membr Biol 110: 87–95, 1989.
Cramer SC, Pardridge WM, Hirayama BA, Wright EM. Colocalization of GLUT2 glucose transporter, sodium/ glucose cotransporter, and γ-glutamyl transpeptidase in rat kidney with double-peroxidase immunocytochemistry.Diabetes 42: 766–770, 1992.
Knight T, Sansom S, Weinman EJ. Renal tubular absorption ofd-glucose, 3-O-methyl-d-glucose and 2-deoxy-d-glucose.Am J Physiol 233: F274–277, 1977.
Silverman M, Black J. High affinity phlorizin receptor sites and their relation to the glucose transport mechanism in the proximal tubule of dog kidney.Biochim Biophys Acta 394: 10–30, 1975.
Turner RJ, Silverman M. Sugar uptake into brush border vesicles from normal human kidney.Proc Natl Acad Sci USA 74: 2825–2829, 1977.
Miller JH, Mullin JM, McAvoy E, Kleinzeller A. Polarity of transport of 2-deoxy-d-glucose andd-glucose by cultured renal epithelia (LLC-PK1).Biochim Biophys Acta 1110: 209–217, 1992.
White MF. The transport of cationic amino acids across the plasma membrane of mammalian cells.Biochim Biophys Acta 822: 355–374, 1985.
Dornhorst A, Powell SH, Pensky J. Aggraviation by propranolol of hyperglycemic effect of hydrochlorothiazide in type II diabetics without alternation of insulin secretion.Lancet i: 123–126, 1985.
Struthers AD. The choice of antihypertensive therapy in the diabetic patient.Postgrad Med J 61: 563–569, 1985.
Sandstrom PE, Sehlin J. Furosemide causes acute and longterm hyperglycaemia and reduce glucose tolerance in mice.Acta Physiol Scand 132: 75–81, 1988.
Sandstrom PE, Sehlin J, Amark K. Furosemide treatment causes age-dependent glucose intolerance and islet damage in obese-hyperglycaemic mice.Pharmacol Toxicol 72: 304–309, 1993.
Fuhrman FA. Glycogen, glucose tolerance and tissue metabolism in potassium-depleted rats.Am J Physiol 167: 314–320, 1951.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kosuda, S., Fisher, S. & Wahl, R.L. Animal studies on the reduction and/or dilution of 2-deoxy-2-[18F]fluoro-d-glucose (FDG) activity in the urinary system. Ann Nucl Med 11, 213–218 (1997). https://doi.org/10.1007/BF03164766
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164766